Yunfu Cui

3.6k total citations
103 papers, 2.7k citations indexed

About

Yunfu Cui is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Yunfu Cui has authored 103 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 64 papers in Cancer Research and 47 papers in Surgery. Recurrent topics in Yunfu Cui's work include Cancer-related molecular mechanisms research (41 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (36 papers) and RNA modifications and cancer (29 papers). Yunfu Cui is often cited by papers focused on Cancer-related molecular mechanisms research (41 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (36 papers) and RNA modifications and cancer (29 papers). Yunfu Cui collaborates with scholars based in China, Hong Kong and United States. Yunfu Cui's co-authors include Yi Xu, Xingming Jiang, Zhidong Wang, Xiangyu Zhong, Kaiming Leng, Zhenglong Li, Yue Yao, Pengcheng Kang, Jinglin Li and Lining Huang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Yunfu Cui

102 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunfu Cui China 28 1.9k 1.8k 698 383 204 103 2.7k
Mingyue Tan China 27 1.6k 0.8× 951 0.5× 353 0.5× 272 0.7× 266 1.3× 75 2.3k
Elisa Callegari Italy 22 2.4k 1.3× 2.1k 1.2× 173 0.2× 223 0.6× 150 0.7× 39 3.1k
Fuqing Zeng China 24 2.0k 1.0× 1.5k 0.8× 195 0.3× 214 0.6× 185 0.9× 87 2.5k
Zhi‐Feng Miao China 30 1.4k 0.7× 796 0.4× 450 0.6× 682 1.8× 436 2.1× 81 2.5k
Peng Gao China 30 2.3k 1.2× 1.8k 1.0× 206 0.3× 425 1.1× 277 1.4× 151 3.1k
Rui Zhou China 25 1.8k 0.9× 1.4k 0.8× 218 0.3× 485 1.3× 321 1.6× 86 2.8k
Takeshi Yamasaki Japan 22 1.1k 0.5× 702 0.4× 288 0.4× 168 0.4× 321 1.6× 103 2.0k
Beifang Ning China 23 1.4k 0.7× 929 0.5× 235 0.3× 509 1.3× 108 0.5× 36 2.2k
Anquan Shang China 25 1.4k 0.8× 1.1k 0.6× 143 0.2× 332 0.9× 176 0.9× 86 2.1k

Countries citing papers authored by Yunfu Cui

Since Specialization
Citations

This map shows the geographic impact of Yunfu Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunfu Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunfu Cui more than expected).

Fields of papers citing papers by Yunfu Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunfu Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunfu Cui. The network helps show where Yunfu Cui may publish in the future.

Co-authorship network of co-authors of Yunfu Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Yunfu Cui. A scholar is included among the top collaborators of Yunfu Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunfu Cui. Yunfu Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Jianjun, Jiangang Wang, Xinlei Zou, et al.. (2024). Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma. Journal of Cancer. 15(8). 2214–2228. 1 indexed citations
2.
Wang, Jiangang, Jianjun Gao, Xinlei Zou, et al.. (2024). Utilization of 3D printing technology in hepatopancreatobiliary surgery. Journal of Zhejiang University SCIENCE B. 25(2). 123–134. 4 indexed citations
3.
Liu, Tong, et al.. (2024). Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma. Frontiers in Immunology. 15. 1455716–1455716. 4 indexed citations
4.
5.
Xu, Yi, Yue Yao, Liang Yu, et al.. (2023). Clathrin light chain A‐enriched small extracellular vesicles remodel microvascular niche to induce hepatocellular carcinoma metastasis. Journal of Extracellular Vesicles. 12(8). e12359–e12359. 15 indexed citations
6.
Xu, Yi, Yue Yao, Liang Yu, et al.. (2023). Clathrin light chain A facilitates small extracellular vesicle uptake to promote hepatocellular carcinoma progression. Hepatology International. 17(6). 1490–1499. 7 indexed citations
7.
Wang, Yudan, Haoming Xia, Shuqiang Liu, et al.. (2023). Roles and Molecular Mechanisms of Biomarkers in Hepatocellular Carcinoma with Microvascular Invasion: A Review. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 14 indexed citations
8.
Zhou, Yongxu, Liang Yu, Peng Huang, et al.. (2023). Identification of afatinib-associated ADH1B and potential small-molecule drugs targeting ADH1B for hepatocellular carcinoma. Frontiers in Pharmacology. 14. 1166454–1166454. 5 indexed citations
9.
10.
Huang, Ziyue, Haoming Xia, Yunfu Cui, Judy Wai Ping Yam, & Yi Xu. (2022). Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 25 indexed citations
11.
Wang, Hang, Liang Yu, Peng Huang, et al.. (2022). Tumor-associated Exosomes Are Involved in Hepatocellular Carcinoma Tumorigenesis, Diagnosis, and Treatment. Journal of Clinical and Translational Hepatology. 10(3). 496–508. 13 indexed citations
12.
Zheng, Wangyang, Daolin Ji, Yongxu Zhou, et al.. (2021). Exosomal Noncoding RNAs in Hepatobiliary Cancer: A Rising Star. Molecular Cancer Therapeutics. 20(10). 1777–1788. 3 indexed citations
13.
14.
Huang, Lining, Xingming Jiang, Zhenglong Li, et al.. (2020). Linc00473 potentiates cholangiocarcinoma progression by modulation of DDX5 expression via miR-506 regulation. Cancer Cell International. 20(1). 324–324. 11 indexed citations
15.
Li, Jinglin, Xingming Jiang, Zhenglong Li, et al.. (2018). Long noncoding RNA GHET1 in human cancer. Clinica Chimica Acta. 488. 111–115. 15 indexed citations
16.
Ding, Chao, et al.. (2018). MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinoma. Biomedicine & Pharmacotherapy. 110. 528–536. 23 indexed citations
17.
Sun, Cheng, Lining Huang, Zhenglong Li, et al.. (2018). Long non-coding RNA MIAT in development and disease: a new player in an old game. Journal of Biomedical Science. 25(1). 23–23. 93 indexed citations
18.
Li, Jinglin, Zhenglong Li, Wangyang Zheng, et al.. (2017). PANDAR: a pivotal cancer-related long non-coding RNA in human cancers. Molecular BioSystems. 13(11). 2195–2201. 21 indexed citations
19.
Kang, Pengcheng, Ming Wan, Peng Huang, et al.. (2014). The Wnt Antagonist sFRP1 as a Favorable Prognosticator in Human Biliary Tract Carcinoma. PLoS ONE. 9(3). e90308–e90308. 24 indexed citations
20.
Liu, Shi, et al.. (2012). Investigation of Borrelia spp. in ticks (Acari: Ixodidae) at the border crossings between China and Russia in Heilongjiang Province, China. Asian Pacific Journal of Tropical Medicine. 5(6). 459–464. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingyue Tan Breakdown of academic impact, for papers by Elisa Callegari Breakdown of academic impact, for papers by Fuqing Zeng Breakdown of academic impact, for papers by Zhi‐Feng Miao Breakdown of academic impact, for papers by Peng Gao Breakdown of academic impact, for papers by Rui Zhou Breakdown of academic impact, for papers by Takeshi Yamasaki Breakdown of academic impact, for papers by Beifang Ning Breakdown of academic impact, for papers by Anquan Shang
Rankless by CCL
2026